首页 / 资讯详情
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
摘要
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
本站为资讯聚合平台，仅展示标题与摘要，原文版权归原发布方所有；如有侵权请联系我们删除。